
Inorganic Chemistry p. 15968 - 15974 (2021)
Update date:2022-08-17
Topics:
Stauffer, Molly
Sakhaei, Zeinab
Greene, Christine
Ghosh, Pokhraj
Bertke, Jeffery A.
Warren, Timothy H.
Nitric oxide (NO) is a key signaling molecule in health and disease. While nitrite acts as a reservoir of NO activity, mechanisms for NO release require further understanding. A series of electronically varied β-diketiminatocopper(II) nitrite complexes [CuII](κ2-O2N) react with a range of electronically tuned triarylphosphines PArZ3 that release NO with the formation of O═PArZ3. Second-order rate constants are largest for electron-poor copper(II) nitrite and electron-rich phosphine pairs. Computational analysis reveals a transition-state structure energetically matched with experimentally determined activation barriers. The production of NO follows a pathway that involves nitrite isomerization at CuII from κ2-O2N to κ1-NO2 followed by O-atom transfer (OAT) to form O═PArZ3 and [CuI]-NO that releases NO upon PArZ3 binding at CuI to form [CuI]-PArZ3. These findings illustrate important mechanistic considerations involved in NO formation from nitrite via OAT.
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Tianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
Doi:10.1016/j.tetlet.2004.08.011
(2004)Doi:10.1016/j.ejmech.2016.04.044
(2016)Doi:10.1070/MC2004v014n01ABEH001877
(2004)Doi:10.1016/0022-1902(71)80465-7
(1971)Doi:10.1021/ac60140a027
(1958)Doi:10.1246/cl.2000.526
(2000)